CD44 and head and neck squamous cell carcinoma: Consistent with the present findings, CD44 expression is associated with poor prognostic outcome of glioma (38, 39), BLCA (40), STAD (41, 42), HNSCC (43), KIRC (44), LIHC (45), PAAD (46),MESO (47),and THYM (48).